A test due to be launched in North Carolina next month will allow doctors to predict exactly which patients with higher than normal cholesterol levels are at risk of heart disease and who will benefit from cholesterol-lowering drugs. A technique known as proton nuclear magnetic resonance (NMR) spectroscopy, developed by North Carolina based LipoMed, produces a detailed read out of an individual's distribution of the different cholesterol subclasses.